The CREB pathway and memory enhancers (original) (raw)

Targeting the CREB pathway for memory enhancers
by
Tully T, Bourtchouladze R, Scott R, Tallman J.
Helicon Therapeutics, Inc.,
One Bioscience Park Drive,
Farmingdale, New York 11743, USA.
Nat Rev Drug Discov. 2003 Apr;2(4):267-77

ABSTRACT

Today, the clinical notion of 'memory disorder' is largely synonymous with 'Alzheimer's disease.' Only 50% of all dementias are of the Alzheimer's type though, and dementias represent only the more severe of all learning/memory disorders that derive from heredity, disease, injury or age. Perhaps as many as 30 million Americans suffer some type of clinically recognized memory disorder. To date, therapeutic drugs of only one class have been approved for the treatment of Alzheimer's disease. Fortunately, basic research during the past 25 years has begun to define a 'chemistry of brain plasticity,' which is suggesting new gene targets for the discovery of memory enhancers.

CREB New brain cells Fruit-fly memories CREBs and memory The memory switch? Dumb-drug euphoria Calcineurin-inhibition Growing new brain cells The genetics of memory Photographic memory in flies CREB and long-term memory Memory promoters and suppressors

****Refs** and further reading

****HOME** HedWeb Nootropics cocaine.wiki Future Opioids BLTC Research MDMA/Ecstasy Superhapiness? Utopian Surgery? The Abolitionist Project The Hedonistic Imperative The Reproductive Revolution Critique of Huxley's Brave New World

****** The Good Drug Guide The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family